Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kay

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Arthritis Research & Therapy|February 6, 2021
Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized studyJonathan Kay, Janusz Jaworski, Rafal Wojciechowski, et al.
Rheumatology (Oxford, England)|June 18, 2021
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritisDaniel E Furst, Janusz Jaworski, Rafal Wojciechowski, et al.
Annals of the Rheumatic Diseases|January 16, 2021
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trialRené Westhovens, William F C Rigby, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|February 4, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, et al.
Nature Genetics|September 29, 2022
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P Rahrmann, David Shorthouse, Amir Jassim, et al.
Commentary (New York, N.Y.)|March 1, 1994
Abortion: round 1Ronald Dworkin, Jonathan Kay, Christopher M Schnaubelt, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Arthritis Research & Therapy|February 6, 2021
Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized studyJonathan Kay, Janusz Jaworski, Rafal Wojciechowski, et al.
Rheumatology (Oxford, England)|June 18, 2021
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritisDaniel E Furst, Janusz Jaworski, Rafal Wojciechowski, et al.
Annals of the Rheumatic Diseases|January 16, 2021
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trialRené Westhovens, William F C Rigby, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|April 16, 2025
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024Kevin L Winthrop, Joan Bathon, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases|February 4, 2019
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, et al.
Nature Genetics|September 29, 2022
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P Rahrmann, David Shorthouse, Amir Jassim, et al.
Commentary (New York, N.Y.)|March 1, 1994
Abortion: round 1Ronald Dworkin, Jonathan Kay, Christopher M Schnaubelt, et al.
European Urology|November 18, 2015
The Early Effects of Rapid Androgen Deprivation on Human Prostate CancerGreg L Shaw, Hayley Whitaker, Marie Corcoran, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases|December 20, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, et al.
Pageof 18